When to Consult Nephrology
Refer patients to nephrology when eGFR falls below 30 mL/min/1.73 m² (CKD stage G4-G5), as this threshold is associated with improved mortality outcomes and allows timely preparation for renal replacement therapy. 1, 2
Absolute Indications for Nephrology Referral
Based on Kidney Function
- eGFR < 30 mL/min/1.73 m² – All patients at this threshold require nephrology involvement, even if stable, to manage complications (anemia, bone disease, metabolic acidosis) and prepare for potential dialysis 1, 2, 3
- eGFR 30-44 mL/min/1.73 m² – Monitor every 3 months; refer if complications arise or progression is evident 4, 5, 3
Based on Proteinuria/Albuminuria
- Albumin-to-creatinine ratio (ACR) ≥ 300 mg/g (or protein excretion > 1 g/day) – This level indicates high risk for ESRD and may warrant kidney biopsy or immunosuppressive therapy 2, 6, 3
- ACR ≥ 60 mg/g (or protein > 1 g/day) in diabetic patients without adequate response to ACE-inhibitor/ARB therapy 6
Acute Kidney Injury (AKI)
- Serum creatinine rise ≥ 0.3 mg/dL within 48 hours or ≥ 1.5× baseline within 7 days 3
- Abrupt sustained eGFR decline > 20% after excluding reversible causes (volume depletion, medications, obstruction) 2, 3
- AKI requiring continuous renal replacement therapy (CRRT) – Early nephrology consultation reduces mortality (HR 0.47) 7, 8
Urinary Abnormalities
- Persistent hematuria with > 20 RBCs per high-power field or presence of red blood cell casts 2, 3
- Active urinary sediment suggesting glomerulonephritis (requires urgent evaluation) 2, 3
Resistant Hypertension & Electrolyte Disorders
- Hypertension refractory to ≥ 4 antihypertensive agents 2, 3
- Persistent hyperkalemia or hypokalemia not correctable with standard measures 2, 3
Structural & Hereditary Disease
- Hereditary kidney disease (polycystic kidney disease, Alport syndrome) 2, 3
- Recurrent or extensive nephrolithiasis threatening renal function 2, 3
Progressive CKD Requiring Referral
- eGFR decline > 5 mL/min/1.73 m² per year indicates rapid progression 5, 6, 3
- Doubling of albuminuria on repeat testing 3
- Kidney Failure Risk Equation score ≥ 3-5% over 5 years justifies referral independent of eGFR 3
Earlier Referral Considerations (eGFR 45-60 mL/min/1.73 m²)
Refer when non-diabetic kidney disease is suspected, particularly with: 5, 6, 3
- Type 1 diabetes < 10 years duration with persistent albuminuria
- Absence of diabetic retinopathy despite significant proteinuria
- Abnormal renal ultrasound findings
- Active urinary sediment
Urgent/Emergent Nephrology Consultation
- Serum creatinine ≥ 3× baseline or absolute value ≥ 4.0 mg/dL 3
- Suspected rapidly progressive glomerulonephritis (crescentic GN) – Renal prognosis depends on immediate intervention 9
- Severe hyperkalemia or volume overload in ESRD patients 9
- Grade 2-3 AKI (creatinine 2-3× baseline) not improving with conservative measures 3
- Nephrotic syndrome or nephritic syndrome with uncertain etiology 3
Common Pitfalls to Avoid
Late referral is associated with increased mortality after dialysis initiation. 1 Many patients are not seen by nephrologists until shortly before dialysis, which is suboptimal. 1
Do not delay referral based solely on patient age or comorbidities – Even elderly patients with multiple comorbidities benefit from nephrology input for symptom management and conservative care planning. 6
A ≥ 30% reduction in eGFR after starting ACE-inhibitors/ARBs warrants prompt nephrology evaluation, not automatic discontinuation. 3
Not all AKI requires nephrology consultation – Prerenal azotemia from volume depletion or acute tubular necrosis from reversible causes can often be managed in primary care, but consultation is needed if no improvement occurs within 48-72 hours or if the etiology is unclear. 6, 10
Monitoring Frequency Before Referral
- eGFR 45-60 mL/min/1.73 m²: Reassess every 6 months 5, 3
- eGFR 30-44 mL/min/1.73 m²: Reassess every 3 months 5, 3
- After hemodynamically active therapy initiation: Recheck within 7 days if creatinine rises ≥ 20-30% 3
Coordination of Care
Primary care providers should continue managing cardiovascular risk factors, blood pressure control, glycemic control, and avoidance of nephrotoxins (NSAIDs, contrast agents) to slow CKD progression. 2, 3
Nephrologists focus on CKD-specific complications including anemia, mineral-bone disorder, metabolic acidosis, and preparation for renal replacement therapy. 2, 3
Multidisciplinary care teams (including dietitians, pharmacists, social workers) should be available for patients with eGFR < 30 mL/min/1.73 m² or progressive disease. 4, 2, 11